Clearance Summary
OCS Heart Leukocyte Depleting Filter received FDA 510(k) clearance under submission number K231362, sponsored by TransMedics, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2023-10-31.
- Submission: K231362
- Applicant / Sponsor: TransMedics, Inc.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.4260
- Decision date: 2023-10-31
Classification & Regulation
This clearance is catalogued under FDA product code DTM and 21 CFR 870.4260, within the Cardiovascular review panel as a Class II device.